APA (7th ed.) Citation

Garcia-Manero, G., Odenike, O., Amrein, P. C., Steensma, D. P., DeZern, A. E., Michaelis, L. C., . . . Savona, M. R. (2016). Successful Emulation of IV Decitabine Pharmacokinetics with an Oral Fixed-Dose Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine, in Subjects with Myelodysplastic Syndromes (MDS): Final Data of Phase 1 Study. Blood, 128(22), 114. https://doi.org/10.1182/blood.V128.22.114.114

Chicago Style (17th ed.) Citation

Garcia-Manero, Guillermo, et al. "Successful Emulation of IV Decitabine Pharmacokinetics with an Oral Fixed-Dose Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine, in Subjects with Myelodysplastic Syndromes (MDS): Final Data of Phase 1 Study." Blood 128, no. 22 (2016): 114. https://doi.org/10.1182/blood.V128.22.114.114.

MLA (9th ed.) Citation

Garcia-Manero, Guillermo, et al. "Successful Emulation of IV Decitabine Pharmacokinetics with an Oral Fixed-Dose Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine, in Subjects with Myelodysplastic Syndromes (MDS): Final Data of Phase 1 Study." Blood, vol. 128, no. 22, 2016, p. 114, https://doi.org/10.1182/blood.V128.22.114.114.